Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to Assess Lymph Node Metastases in Head and Neck Cancer: A Prospective Study
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Sensitivity and specificity of DCE-CT in predicting the presence of residual lymph node disease after the completion of chemotherapy
8-10 weeks post treatment
No
David A Palma, MD, MSc, PhD
Principal Investigator
London Regional Cancer Program
Canada: Ethics Review Committee
UWO18826
NCT01549379
March 2012
March 2016
Name | Location |
---|